Category Health Tech

TigerConnect® Named a Leader in the 2023 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration

TigerConnect, healthcare’s most trusted clinical collaboration platform, today announced it has been named a Leader in the 2023 Gartner Magic Quadrant for Clinical Communication and Collaboration (CC&C). The evaluation was…

Read MoreTigerConnect® Named a Leader in the 2023 Gartner® Magic Quadrant™ for Clinical Communication and Collaboration

For the First Time Bioelectronic Medicine Researchers at The Feinstein Institutes Restore Feeling and Lasting Movement in Man Living With Quadriplegia

In a first-of-its-kind clinical trial, bioelectronic medicine researchers, engineers and surgeons at Northwell Health’s The Feinstein Institutes for Medical Research have successfully implanted microchips into the brain of a man living with paralysis,…

Read MoreFor the First Time Bioelectronic Medicine Researchers at The Feinstein Institutes Restore Feeling and Lasting Movement in Man Living With Quadriplegia

bspr Inc. and BHQ Corp. to Release First Smartphone App “Braincure” Beta Version Encompassing BHQ Actions for Brain Health, in the United States in September

bspr Inc. (Shibuya-ku, Tokyo, CEO: Yosuke Toyama), in collaboration with BHQ Corp. (Saitama City, Saitama Prefecture, CEO: Masahito Kawamori), is pleased to announce the release of the beta version of…

Read Morebspr Inc. and BHQ Corp. to Release First Smartphone App “Braincure” Beta Version Encompassing BHQ Actions for Brain Health, in the United States in September

Impetus Grants Secures $10 million Commitment from Hevolution Foundation and Rosenkranz Foundation to Fund Aging Science

Impetus Grants, a nonprofit foundation dedicated to funding aging-related research that might otherwise be overlooked by traditional funding sources, announces a new round of matching funding. Hevolution Foundation, a global non-profit…

Read MoreImpetus Grants Secures $10 million Commitment from Hevolution Foundation and Rosenkranz Foundation to Fund Aging Science

United States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma

Anova Enterprises, Inc. (Anova), an organization dedicated to accelerating the development of promising treatments to market announced the FDA authorization of a Phase II clinical trial to re-assess a targeted…

Read MoreUnited States Food and Drug Administration (FDA) Authorizes Phase 2 Study of DB107 In Promising Turn-Around of Targeted Treatment to Treat Newly Diagnosed High Grade Glioma